INS and type 2 diabetes mellitus: Such improvements in insulin sensitivity in metabolically active organs may improve systemic insulin resistance, which may change the insulin resistance milieu in adipose tissue in patients with type 2 diabetes, such as via an increase in adiponectin and a decrease in inflammatory cytokines.